Reducing Racial Inequalities in Prostate Cancer Treatment: Healthcare Access Barriers

Area of Science:

• Oncology
• Health Disparities Research
• Epidemiology

Background:

• Prostate cancer disproportionately affects Black men, leading to higher incidence and mortality rates.
• Existing healthcare inequalities contribute to significant treatment and survival disparities for prostate cancer patients.
• Equitable treatment and access to clinical trials can improve survival outcomes for Black men with prostate cancer.

Purpose of the Study:

• To identify factors contributing to inequitable treatment of prostate cancer in Black men compared to White men.
• To highlight the need for interventions that address healthcare disparities in prostate cancer care.
• To inform strategies aimed at improving health equity and survival for Black men diagnosed with prostate cancer.

Main Methods:

• Analysis of treatment patterns and outcomes in a cohort of prostate cancer patients.
• Comparison of treatment appropriateness between Black and White patient groups.
• Review of healthcare access and clinical trial participation factors.

Main Results:

• Black men with prostate cancer are less likely to receive appropriate treatment compared to their White counterparts.
• Despite similar or better survival in clinical trials, Black men face barriers to equitable care.
• Disparities in treatment access and appropriateness contribute to adverse outcomes.

Conclusions:

• Inequitable healthcare access and treatment contribute to prostate cancer mortality disparities.
• Urgent identification and mitigation of factors causing these disparities are essential.
• Achieving health equity in prostate cancer care is critical for improving survival among Black men.